Your browser doesn't support javascript.
loading
Highlight of 2023: Virtues and vices of CD4 CAR T cells.
Chinni, Shivali Savita; Taylor, Megan F; Borger, Jessica G; Quinn, Kylie M.
Affiliation
  • Chinni SS; School of Health and Biomedical Sciences, RMIT University, Bundoora, VIC, Australia.
  • Taylor MF; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Borger JG; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia.
  • Quinn KM; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
Immunol Cell Biol ; 102(6): 432-436, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38659345
ABSTRACT
This article for the Highlights of 2023 Series explores recent work that suggests that targeting CD4 CAR T cells may be critical for both of these challenges.
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Immunotherapy, Adoptive / Receptors, Chimeric Antigen Limits: Animals / Humans Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Immunotherapy, Adoptive / Receptors, Chimeric Antigen Limits: Animals / Humans Language: En Journal: Immunol Cell Biol Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Type: Article Affiliation country: Australia